(Q33926160)

30 July 2017

Bupropion-SR in treatment of social phobia (English)

1 reference

30 July 2017

Emmanuel NP

1

1 reference

30 July 2017

Brawman-Mintzer O

2

1 reference

30 July 2017

Morton WA

3

1 reference

30 July 2017

Book SW

4

1 reference

30 July 2017

Johnson MR

5

1 reference

30 July 2017

Lorberbaum JP

6

1 reference

30 July 2017

Ballenger JC

7

1 reference

30 July 2017

Lydiard RB

8

1 reference

30 July 2017

1 January 2000

1 reference

30 July 2017

Depression and Anxiety

1 reference

30 July 2017

12

1 reference

30 July 2017

111-113

1 reference

30 July 2017

2

1 reference

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

30 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A2%3C111%3A%3AAID-DA9%3E3.0.CO%3B2-3

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A2%3C111%3A%3AAID-DA9%3E3.0.CO%3B2-3

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A2%3C111%3A%3AAID-DA9%3E3.0.CO%3B2-3

Phenelzine v imipramine in atypical depression. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A2%3C111%3A%3AAID-DA9%3E3.0.CO%3B2-3

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A2%3C111%3A%3AAID-DA9%3E3.0.CO%3B2-3

Social phobia. Comorbidity and morbidity in an epidemiologic sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A2%3C111%3A%3AAID-DA9%3E3.0.CO%3B2-3

Imipramine in the treatment of social phobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A2%3C111%3A%3AAID-DA9%3E3.0.CO%3B2-3

Sertraline in social phobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A2%3C111%3A%3AAID-DA9%3E3.0.CO%3B2-3

Social phobia in general health care: an unrecognised undertreated disabling disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A2%3C111%3A%3AAID-DA9%3E3.0.CO%3B2-3

Anxiety and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A2%3C111%3A%3AAID-DA9%3E3.0.CO%3B2-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A2%3C111%3A%3AAID-DA9%3E3.0.CO%3B2-3

The Boundary of Social Phobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A2%3C111%3A%3AAID-DA9%3E3.0.CO%3B2-3

10.1002/1520-6394(2000)12:2<111::AID-DA9>3.0.CO;2-3

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference